Oh HA et al. |
Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos. |
2013 |
Mol. Hum. Reprod. |
pmid:23112252
|
Maccarrone M et al. |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. |
2005 |
Mol. Hum. Reprod. |
pmid:15563449
|
Maccarrone M et al. |
Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. |
2002 |
Mol. Hum. Reprod. |
pmid:11818522
|
Felder CC et al. |
Cannabinoids biology: the search for new therapeutic targets. |
2006 |
Mol. Interv. |
pmid:16809476
|
van der Stelt M et al. |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. |
2002 Oct-Dec |
Mol. Neurobiol. |
pmid:12428763
|
Luchicchi A and Pistis M |
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. |
2012 |
Mol. Neurobiol. |
pmid:22801993
|
Kim SR et al. |
Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity. |
2007 |
Mol. Neurobiol. |
pmid:17917113
|
Zhang X et al. |
Agonist-dependent potentiation of vanilloid receptor transient receptor potential vanilloid type 1 function by stilbene derivatives. |
2012 |
Mol. Pharmacol. |
pmid:22328719
|
Snider NT et al. |
A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist. |
2009 |
Mol. Pharmacol. |
pmid:19171674
|
Spivak CE et al. |
The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. |
2007 |
Mol. Pharmacol. |
pmid:17628012
|
Yates ML and Barker EL |
Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. |
2009 |
Mol. Pharmacol. |
pmid:19389920
|
Meuth SG et al. |
The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. |
2006 |
Mol. Pharmacol. |
pmid:16424077
|
Xiong W et al. |
Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. |
2008 |
Mol. Pharmacol. |
pmid:17993512
|
Mackie K et al. |
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. |
1993 |
Mol. Pharmacol. |
pmid:8371711
|
Sancho R et al. |
Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. |
2003 |
Mol. Pharmacol. |
pmid:12527815
|
Randall MD |
A new endothelial target for cannabinoids. |
2003 |
Mol. Pharmacol. |
pmid:12606752
|
Pan X et al. |
Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system. |
1996 |
Mol. Pharmacol. |
pmid:8609900
|
McFarland MJ et al. |
RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. |
2008 |
Mol. Pharmacol. |
pmid:18436710
|
Hegde VL et al. |
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. |
2008 |
Mol. Pharmacol. |
pmid:18388242
|
Gonsiorek W et al. |
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. |
2000 |
Mol. Pharmacol. |
pmid:10779390
|
Felder CC et al. |
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. |
1995 |
Mol. Pharmacol. |
pmid:7565624
|
Moreno-Galindo EG et al. |
Molecular basis for a high-potency open-channel block of Kv1.5 channel by the endocannabinoid anandamide. |
2010 |
Mol. Pharmacol. |
pmid:20133392
|
Hejazi N et al. |
Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. |
2006 |
Mol. Pharmacol. |
pmid:16332990
|
Lizanecz E et al. |
Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. |
2006 |
Mol. Pharmacol. |
pmid:16338989
|
Guo J and Ikeda SR |
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. |
2004 |
Mol. Pharmacol. |
pmid:14978245
|
Day TA et al. |
Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. |
2001 |
Mol. Pharmacol. |
pmid:11353795
|
Theile JW and Cummins TR |
Inhibition of Navβ4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide. |
2011 |
Mol. Pharmacol. |
pmid:21788423
|
Breivogel CS et al. |
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. |
2001 |
Mol. Pharmacol. |
pmid:11408610
|
Priller J et al. |
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. |
1995 |
Mol. Pharmacol. |
pmid:7651362
|
Edgemond WS et al. |
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. |
1998 |
Mol. Pharmacol. |
pmid:9658204
|
Andersson DA et al. |
Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. |
2002 |
Mol. Pharmacol. |
pmid:12181448
|
Neumeister A et al. |
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. |
2013 |
Mol. Psychiatry |
pmid:23670490
|
Gunduz-Cinar O et al. |
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. |
2013 |
Mol. Psychiatry |
pmid:22688188
|
Schuel H et al. |
Evidence that anandamide-signaling regulates human sperm functions required for fertilization. |
2002 |
Mol. Reprod. Dev. |
pmid:12237954
|
Paria BC et al. |
The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. |
1996 |
Mol. Reprod. Dev. |
pmid:8914076
|
Muccioli GG et al. |
The endocannabinoid system links gut microbiota to adipogenesis. |
2010 |
Mol. Syst. Biol. |
pmid:20664638
|
Pisani V et al. |
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients. |
2010 |
Mov. Disord. |
pmid:20461809
|
Pryce G et al. |
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. |
2013 |
Mult. Scler. |
pmid:23625705
|
Pastuhov SI et al. |
Endocannabinoid-Goα signalling inhibits axon regeneration in Caenorhabditis elegans by antagonizing Gqα-PKC-JNK signalling. |
2012 |
Nat Commun |
pmid:23072806
|
Alpár A et al. |
Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. |
2014 |
Nat Commun |
pmid:25030704
|
Mechoulam R and Ben-Shabat S |
From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. |
1999 |
Nat Prod Rep |
pmid:10331283
|
Nomura DK et al. |
Activation of the endocannabinoid system by organophosphorus nerve agents. |
2008 |
Nat. Chem. Biol. |
pmid:18438404
|
Long JZ et al. |
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. |
2009 |
Nat. Chem. Biol. |
pmid:19029917
|
Voets T et al. |
Sensing with TRP channels. |
2005 |
Nat. Chem. Biol. |
pmid:16408004
|
Fields HL and Meng ID |
Watching the pot boil. |
1998 |
Nat. Med. |
pmid:9734389
|
Stock K et al. |
Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. |
2012 |
Nat. Med. |
pmid:22820645
|
Piomelli D |
THC: moderation during implantation. |
2004 |
Nat. Med. |
pmid:14702623
|
Kathuria S et al. |
Modulation of anxiety through blockade of anandamide hydrolysis. |
2003 |
Nat. Med. |
pmid:12461523
|
Jourdan T et al. |
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. |
2013 |
Nat. Med. |
pmid:23955712
|
Bátkai S et al. |
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. |
2001 |
Nat. Med. |
pmid:11433348
|
Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Marsicano G and Chaouloff F |
Moving bliss: a new anandamide transporter. |
2012 |
Nat. Neurosci. |
pmid:22193249
|
Self DW |
Anandamide: a candidate neurotransmitter heads for the big leagues. |
1999 |
Nat. Neurosci. |
pmid:10204533
|
Giuffrida A et al. |
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. |
1999 |
Nat. Neurosci. |
pmid:10204543
|
Kim J and Alger BE |
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. |
2010 |
Nat. Neurosci. |
pmid:20348918
|
Maccarrone M et al. |
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. |
2008 |
Nat. Neurosci. |
pmid:18204441
|
Di Marzo V |
Anandamide serves two masters in the brain. |
2010 |
Nat. Neurosci. |
pmid:21102567
|
Clapper JR et al. |
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. |
2010 |
Nat. Neurosci. |
pmid:20852626
|
Di Marzo V |
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. |
2011 |
Nat. Neurosci. |
pmid:21187849
|
Chávez AE et al. |
TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. |
2010 |
Nat. Neurosci. |
pmid:21076423
|
Fu J et al. |
A catalytically silent FAAH-1 variant drives anandamide transport in neurons. |
2012 |
Nat. Neurosci. |
pmid:22101642
|
Gerdeman GL et al. |
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. |
2002 |
Nat. Neurosci. |
pmid:11976704
|
Balas L et al. |
Synthesis of a photoactivatable probe of the anandamide re-uptake. |
2005 |
Nat. Prod. Res. |
pmid:15938150
|
Mechoulam R et al. |
Anandamide may mediate sleep induction. |
1997 |
Nature |
pmid:9288961
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Iversen L |
Pharmacology. Endogenous cannabinoids. |
1994 |
Nature |
pmid:7990950
|
Calignano A et al. |
Control of pain initiation by endogenous cannabinoids. |
1998 |
Nature |
pmid:9685157
|
Di Marzo V et al. |
Formation and inactivation of endogenous cannabinoid anandamide in central neurons. |
1994 |
Nature |
pmid:7990962
|
Zygmunt PM et al. |
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. |
1999 |
Nature |
pmid:10440374
|
Iversen LL |
Pharmacology. Medical uses of marijuana? |
1993 |
Nature |
pmid:8395659
|
Munro S et al. |
Molecular characterization of a peripheral receptor for cannabinoids. |
1993 |
Nature |
pmid:7689702
|
Premkumar LS and Ahern GP |
Induction of vanilloid receptor channel activity by protein kinase C. |
2000 Dec 21-28 |
Nature |
pmid:11140687
|
di Tomaso E et al. |
Brain cannabinoids in chocolate. |
1996 |
Nature |
pmid:8751435
|
RodrÃguez de Fonseca F et al. |
An anorexic lipid mediator regulated by feeding. |
2001 |
Nature |
pmid:11700558
|
Davis JB et al. |
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. |
2000 |
Nature |
pmid:10821274
|
Venance L et al. |
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. |
1995 |
Nature |
pmid:7637807
|
Watanabe H et al. |
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. |
2003 |
Nature |
pmid:12879072
|
Cravatt BF et al. |
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. |
1996 |
Nature |
pmid:8900284
|
Calignano A et al. |
Bidirectional control of airway responsiveness by endogenous cannabinoids. |
2000 |
Nature |
pmid:11081515
|
Mechoulam R and Fride E |
Physiology. A hunger for cannabinoids. |
2001 |
Nature |
pmid:11298428
|
Mechoulam R |
Todd's achievement. |
1997 |
Nature |
pmid:9126725
|
Wagner JA et al. |
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. |
1997 |
Nature |
pmid:9394002
|
Stella N et al. |
A second endogenous cannabinoid that modulates long-term potentiation. |
1997 |
Nature |
pmid:9285589
|
Barthó L et al. |
Nitric oxide is involved in the relaxant effect of capsaicin in the human sigmoid colon circular muscle. |
2002 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:12382081
|
Holt S and Fowler CJ |
Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:12644895
|
Schulte K et al. |
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor. |
2012 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:22215206
|
del Carmen GarcÃa M et al. |
Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:14504685
|
Baranowska-Kuczko M et al. |
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24682422
|
Molderings GJ et al. |
Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship. |
1999 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10494885
|
Akinshola BE et al. |
Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. |
1999 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10543424
|
Fisar Z |
Inhibition of monoamine oxidase activity by cannabinoids. |
2010 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:20401651
|
Malinowska B et al. |
Involvement of central beta2-adrenergic, NMDA and thromboxane A2 receptors in the pressor effect of anandamide in rats. |
2010 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:20198363
|
Terranova JP et al. |
Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. |
1995 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:8751088
|
Zygmunt PM et al. |
Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10832608
|
Ilayan E et al. |
Do cannabinoids exhibit a tyramine-like effect? |
2013 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:23900610
|
Avelino A and Cruz F |
TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. |
2006 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:16721555
|
Jergas B et al. |
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24853577
|
Steffens M et al. |
Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:14566450
|
Kracke GR et al. |
The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes. |
2007 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:17960365
|
Crozier Willi G et al. |
Lipids in neural function: modulation of behavior by oral administration of endocannabinoids found in foods. |
2001 |
Nestle Nutr Workshop Ser Clin Perform Programme |
pmid:11510437
|